See what’s happening at MBC BioLabs.
BioInnovation Labs (BioLabs), LabCentral and MBC BioLabs Announce Strategic Partnership with AbbVie to Boost Innovation in key biotech clusters in the US and Europe.
BioLabs, LabCentral and MBC BioLabs are excited to announce a five-year strategic partnership with AbbVie, a global biopharmaceutical company. AbbVie has long been a champion of the three organizations’ shared vision for advancing biotech entrepreneurship and continues to play a critical role in the networks they have cultivated over the past decade.
BridgeBio’s Attruby™ (acoramidis) approved by FDA to reduce cardiovascular death and cardiovascular-related hospitalization in ATTR-CM patients
The U.S. Food and Drug Administration (FDA) approved Attruby™ (acoramidis), an orally-administered near-complete (≥90%) stabilizer of Transthyretin (TTR) for the treatment of adults with ATTR-CM to reduce cardiovascular death and cardiovascular-related hospitalization. The FDA approval is based on positive results seen in the ATTRibute-CM Phase 3 study, where Attruby significantly reduced death and cardiovascular-related hospitalization, and improved quality of life.
OneSkin closes $20M series A investment round, fueling the future of skin longevity with advanced research
OneSkin is a best-in-class biotech skin health brand on a mission to revolutionize how we age. Created by four pioneering female scientists - OneSkin believes in research first, products second. That's why its founders spent five years analyzing over 900 peptides before discovering OS-01, the first ingredient scientifically proven to reverse skin's biological age.
BioLabs, LabCentral and MBC BioLabs are excited to announce a five-year strategic partnership with AbbVie, a global biopharmaceutical company. AbbVie has long been a champion of the three organizations’ shared vision for advancing biotech entrepreneurship and continues to play a critical role in the networks they have cultivated over the past decade.
The U.S. Food and Drug Administration (FDA) approved Attruby™ (acoramidis), an orally-administered near-complete (≥90%) stabilizer of Transthyretin (TTR) for the treatment of adults with ATTR-CM to reduce cardiovascular death and cardiovascular-related hospitalization. The FDA approval is based on positive results seen in the ATTRibute-CM Phase 3 study, where Attruby significantly reduced death and cardiovascular-related hospitalization, and improved quality of life.
OneSkin is a best-in-class biotech skin health brand on a mission to revolutionize how we age. Created by four pioneering female scientists - OneSkin believes in research first, products second. That's why its founders spent five years analyzing over 900 peptides before discovering OS-01, the first ingredient scientifically proven to reverse skin's biological age.
Pre-Opening Celebration for 1030 Brittan
February 27 @ 4 – 7pm
Location:
1030 Brittan Ave · San Carlos
Fika, A New MBC BioLabs Tradition!
According to Doug Crawford, there are a few key things that scientists need in order to succeed in the labs: one of them being coffee, and the other is snacks! Our newly adapted weekly tradition of Fika was inspired by the Swedish culture. Fika, which roughly translates from Swedish as drinking coffee, munching sweet treats and chatting — is as much a part of the working day in Sweden as emailing and fixing the printer.
